329 related articles for article (PubMed ID: 8891017)
1. Differential expression of desmosomal glycoproteins in keratoacanthoma and squamous cell carcinoma of the skin: an immunohistochemical aid to diagnosis.
Krunic AL; Garrod DR; Smith NP; Orchard GS; Cvijetic OB
Acta Derm Venereol; 1996 Sep; 76(5):394-8. PubMed ID: 8891017
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin.
Krunic AL; Garrod DR; Madani S; Buchanan MD; Clark RE
Br J Cancer; 1998 Apr; 77(8):1275-9. PubMed ID: 9579833
[TBL] [Abstract][Full Text] [Related]
3. VCAM (CD-106) and ICAM (CD-54) adhesion molecules distinguish keratoacanthomas from cutaneous squamous cell carcinomas.
Melendez ND; Smoller BR; Morgan M
Mod Pathol; 2003 Jan; 16(1):8-13. PubMed ID: 12527707
[TBL] [Abstract][Full Text] [Related]
4. Desmoglein in multiple self-healing squamous epithelioma of Ferguson-Smith--comparison of staining patterns with actinic keratoacanthoma and squamous cell carcinoma of the skin.
Krunic AL; Garrod DR; Hunter JA; Clark RE
Arch Dermatol Res; 1998 Jun; 290(6):319-24. PubMed ID: 9705163
[TBL] [Abstract][Full Text] [Related]
5. Abnormal desmoglein expression by squamous cell carcinoma cells.
Harada H; Iwatsuki K; Ohtsuka M; Han GW; Kaneko F
Acta Derm Venereol; 1996 Nov; 76(6):417-20. PubMed ID: 8982400
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor alpha expression helps to distinguish keratoacanthomas from squamous cell carcinomas.
Ho T; Horn T; Finzi E
Arch Dermatol; 1991 Aug; 127(8):1167-71. PubMed ID: 1863074
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical staining of desmosomal components in oral squamous cell carcinomas and its association with tumour behaviour.
Hiraki A; Shinohara M; Ikebe T; Nakamura S; Kurahara S; Garrod DR
Br J Cancer; 1996 Jun; 73(12):1491-7. PubMed ID: 8664118
[TBL] [Abstract][Full Text] [Related]
8. Cytokeratin 10 and Ki-67 nuclear marker expression in keratoacanthoma and squamous cell carcinoma.
Basta-Juzbasić A; Klenkar S; Jakić-Razumović J; Pasić A; Loncarić D
Acta Dermatovenerol Croat; 2004; 12(4):251-6. PubMed ID: 15588557
[TBL] [Abstract][Full Text] [Related]
9. Carcinoma-like vascular density in atypic keratoacanthoma suggests malignant progression.
Strieth S; Hartschuh W; Pilz L; Fusenig NE
Br J Cancer; 2002 Nov; 87(11):1301-7. PubMed ID: 12439721
[TBL] [Abstract][Full Text] [Related]
10. Expression of desmoglein I and plakoglobin in skin carcinomas.
Tada H; Hatoko M; Tanaka A; Kuwahara M; Muramatsu T
J Cutan Pathol; 2000 Jan; 27(1):24-9. PubMed ID: 10660128
[TBL] [Abstract][Full Text] [Related]
11. Are keratoacanthomas really squamous cell carcinomas?
Sanders GH; Miller TA
Ann Plast Surg; 1982 Oct; 9(4):306-9. PubMed ID: 7149561
[TBL] [Abstract][Full Text] [Related]
12. The potential role of abnormal E-cadherin and alpha-, beta- and gamma-catenin immunoreactivity in the determination of the biological behaviour of keratoacanthoma.
Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
Br J Dermatol; 2001 Oct; 145(4):582-9. PubMed ID: 11703284
[TBL] [Abstract][Full Text] [Related]
13. Stereological estimation of mean nuclear volume and staining pattern of Ki-67 antigen in keratoacanthomas and squamous cell carcinomas.
Sağol O; Kurtoğlu B; Ozer E; Pabuççuoğlu U
Gen Diagn Pathol; 1998 Apr; 143(5-6):305-9. PubMed ID: 9653912
[TBL] [Abstract][Full Text] [Related]
14. Metastasizing keratoacanthomas? The difficulties in differentiating keratoacanthomas from squamous cell carcinomas.
Schnur PL; Bozzo P
Plast Reconstr Surg; 1978 Aug; 62(2):258-62. PubMed ID: 674415
[TBL] [Abstract][Full Text] [Related]
15. Utility of peanut agglutinin (PNA) in the diagnosis of squamous cell carcinoma and keratoacanthoma.
Kannon G; Park HK
Am J Dermatopathol; 1990 Feb; 12(1):31-6. PubMed ID: 2180338
[TBL] [Abstract][Full Text] [Related]
16. Keratoacanthoma: a deficient squamous cell carcinoma? Study of bcl-2 expression.
Sleater JP; Beers BB; Stephens CA; Hendricks JB
J Cutan Pathol; 1994 Dec; 21(6):514-9. PubMed ID: 7699118
[TBL] [Abstract][Full Text] [Related]
17. Keratoacanthoma and squamous cell carcinoma of the skin: immunohistochemical localization of involucrin and keratin proteins.
Smoller BR; Kwan TH; Said JW; Banks-Schlegel S
J Am Acad Dermatol; 1986 Feb; 14(2 Pt 1):226-34. PubMed ID: 2419374
[TBL] [Abstract][Full Text] [Related]
18. Pattern of TGFbeta receptor 1 expression differs between kras-mutated keratoacanthomas and squamous cell carcinomas of the skin.
Berger F; Geddert H; Faller G; Werner M; Dimmler A
Pathol Res Pract; 2014 Sep; 210(9):596-602. PubMed ID: 24954139
[TBL] [Abstract][Full Text] [Related]
19. [The value of laminin-322 staining in distinguishing between keratoacanthoma, keratoacanthoma with areas of squamous cell carcinoma, and crateriform squamous cell carcinoma].
Corbalán-Vélez R; Martínez-Barba E; López-Poveda MJ; Vidal-Abarca Gutiérrez I; Ruíz-Maciá JA; Oviedo-Ramirez I; Martínez-Menchón T
Actas Dermosifiliogr; 2012 May; 103(4):308-16. PubMed ID: 22176864
[TBL] [Abstract][Full Text] [Related]
20. Differential diagnosis of keratoacanthomas and squamous cell carcinomas: diagnostic value of DNA image cytometry and p53 expression.
Pilch H; Weiss J; Heubner C; Heine M
J Cutan Pathol; 1994 Dec; 21(6):507-13. PubMed ID: 7699117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
